Chronic myeloid leukemia (CML) is characterized by the expression of the BCR/ABL1 fusion gene and the presence of the Philadelphia chromosome (Ph). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.